ACM
MLAB icon

Atlanta Capital Management’s Mesa Laboratories MLAB Stock Holding History

Atlanta Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$23.3M Sell
165,321
-5,864
-3% -$1.07M 0.1% 147
2022
Q2 		$34.9M Buy
171,185
+35,880
+27% +$7.86M 0.15% 133
2022
Q1 		$34.5M Sell
135,305
-466
-0.3% -$127K 0.13% 141
2021
Q4 		$44.5M Sell
135,771
-2,575
-2% -$808K 0.15% 132
2021
Q3 		$41.8M Buy
138,346
+4,191
+3% +$1.19M 0.15% 132
2021
Q2 		$36.4M Buy
134,155
+586
+0.4% +$149K 0.13% 143
2021
Q1 		$32.5M Buy
133,569
+4,565
+4% +$1.26M 0.11% 147
2020
Q4 		$37M Sell
129,004
-6,330
-5% -$1.74M 0.13% 140
2020
Q3 		$34.5M Buy
135,334
+7,465
+6% +$1.77M 0.14% 137
2020
Q2 		$27.7M Buy
127,869
+5,909
+5% +$1.36M 0.12% 142
2020
Q1 		$27.6M Buy
121,960
+7,951
+7% +$1.96M 0.14% 133
2019
Q4 		$28.4M Buy
114,009
+922
+0.8% +$216K 0.12% 134
2019
Q3 		$26.9M Buy
113,087
+657
+0.6% +$152K 0.12% 130
2019
Q2 		$27.5M Sell
112,430
-7,803
-6% -$1.82M 0.12% 127
2019
Q1 		$27.7M Sell
120,233
-5,216
-4% -$1.18M 0.13% 124
2018
Q4 		$26.1M Buy
+125,449
New +$24.5M 0.14% 120

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Atlanta Capital Management's MLAB Position: Q3 2022 in Review

Atlanta Capital Management reduced its Mesa Laboratories (MLAB) stake by 3.4% in Q3 2022, selling an estimated $1.07M and leaving 165,321 shares worth $23.3M. The position accounts for 0.1% of the portfolio, ranked #147.

Atlanta Capital Management first reported a position in MLAB in Q4 2018 and has held it in 16 quarters since. The position peaked at $44.5M in Q4 2021. 163 funds tracked by Wall St. Rank hold MLAB as of Q3 2022.

  • Atlanta Capital Management held 165,321 shares of Mesa Laboratories worth $23.3M as of Q3 2022.
  • Atlanta Capital Management sold 5,864 Mesa Laboratories shares in Q3 2022, an estimated $1.07M.
  • Mesa Laboratories made up 0.1% of Atlanta Capital Management's portfolio in Q3 2022, its #147 holding.
  • Atlanta Capital Management first reported a position in Mesa Laboratories in Q4 2018 and has held it in 16 quarters since.
  • Atlanta Capital Management's Mesa Laboratories position peaked at $44.5M in Q4 2021.
  • 163 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2022.

Based on Atlanta Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.